Multifaceted Implantable Anticancer Device for Potential Postsurgical Breast Cancer Treatment: A Single Platform for Synergistic Inhibition of Local Regional Breast Cancer Recurrence, Surveillance, and Healthy Breast Reconstruction
Source abstract
Abstract
Abstract An implantable anticancer device (IAD) amenable to eradicate local regional recurrence (LRR) of breast cancer as well as to enhance the breast reconstruction during/after therapy is proposed for the first time. The IAD is fabricated by incorporating the superparamagnetic graphene oxide doxorubicin nanocomposite of size ≈200 nm in a nanofiber matrix to enable the sustained and tumor specific anticancer drug release over 60 d in vitro with a minimum initial burst release and the repeated hyperthermic capability in an alternating magnetic field to ensure the synergistic inhibition of LRR. The IAD also enriches the reconstruction of poor breast cosmesis that resulted from the surgical treatment by supporting the lipofilling of the surgical residual cavity to induce the adipogenic process. Moreover, the noninvasive monitoring capability of IAD through magnetic resonance imaging augments to the effective patient care. Thus, this work reports a new and reliable concept by introducing the multifunctional IAD possessing enhanced specificity with a real‐time monitoring capability and long‐term anticancer efficacy as a potential platform for synergistic inhibition of LRR and a great promise for the in situ breast reconstruction ability for better breast cosmesis.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Carbon and Quantum Dots Applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bionanosystem Engineering Graduate School Chonbuk National University Jeonju 561‐756 Republic of Korea
Mechanical Design Engineering Chonbuk National University Jeonju 561‐756 Republic of Korea
Department of Radiology Biomolecular Theranostics (BiT) Lab Chonnam National University Hwasun Hospital Hwasun 58128 South Korea
Funding
National Research Foundation of Korea
References (63)
Show source-provided references
1. 10.3322/caac.2126210.3322/caac.21262 ↗
2. 10.1002/adfm.20150077210.1002/adfm.201500772 ↗
3. 10.1111/tbj.1200910.1111/tbj.12009 ↗
4. 10.1063/1.490373610.1063/1.4903736 ↗
5. Katipamula R. · J. Clin. Oncol. · 2008 · 26 · 50910.1200/jco.2008.26.15_suppl.509 ↗
6. 10.1093/annonc/mdg45210.1093/annonc/mdg452 ↗
7. 10.1007/s12282-007-0001-410.1007/s12282-007-0001-4 ↗
8. 10.1039/c3tb20636j10.1039/c3tb20636j ↗
9. 10.1093/annonc/mdf28010.1093/annonc/mdf280 ↗
10. Habash RW B. R. · Crit. Rev. Biomed. Eng. · 2006 · 34 · 385
11. Baronzio G. · 2013 · 3
12. Kouloulias V. E. · Clin. Cancer Res. · 2002 · 8 · 374
13. 10.1016/S0360-3016(00)01514-510.1016/S0360-3016(00)01514-5 ↗
14. 10.1186/1477-7819-10-20110.1186/1477-7819-10-201 ↗
15. 10.1002/adfm.20150038910.1002/adfm.201500389 ↗
16. 10.1002/adfm.20130074610.1002/adfm.201300746 ↗
17. 10.1163/15685620878452206510.1163/156856208784522065 ↗
18. 10.1002/adfm.20120114010.1002/adfm.201201140 ↗
19. 10.1002/adfm.20160352410.1002/adfm.201603524 ↗
20. 10.1002/adfm.20140180610.1002/adfm.201401806 ↗
21. 10.1016/j.biomaterials.2008.04.00210.1016/j.biomaterials.2008.04.002 ↗
22. 10.1021/acsbiomaterials.6b0029710.1021/acsbiomaterials.6b00297 ↗
23. 10.1039/C5RA17230F10.1039/C5RA17230F ↗
24. 10.3109/10717544.2015.104849010.3109/10717544.2015.1048490 ↗
25. 10.1016/j.jconrel.2012.05.04710.1016/j.jconrel.2012.05.047 ↗
26. 10.1371/journal.pone.016143510.1371/journal.pone.0161435 ↗
27. 10.1089/ten.teb.2009.054410.1089/ten.teb.2009.0544 ↗
28. Miaskowski A. · Przegl. Elektrotech. · 2011 · 87 · 125
29. Lyer S. · Anticancer Res. · 2014 · 34 · 6835
30. 10.1088/0957-4484/25/45/45200110.1088/0957-4484/25/45/452001 ↗
31. 10.1002/adfm.20140276410.1002/adfm.201402764 ↗
32. Yu J. · Nanomedicine · 2016 · 12 · 45910.1016/j.nano.2015.12.037 ↗
33. 10.7150/thno.1154410.7150/thno.11544 ↗
34. 10.1002/adfm.20150418510.1002/adfm.201504185 ↗
35. 10.1039/C4CS00345D10.1039/C4CS00345D ↗
36. 10.1002/adfm.20100165810.1002/adfm.201001658 ↗
37. 10.1039/C0JM02494E10.1039/C0JM02494E ↗
38. 10.1038/srep2054310.1038/srep20543 ↗
39. 10.1016/j.carbpol.2013.10.07010.1016/j.carbpol.2013.10.070 ↗
40. 10.1089/ten.tea.2016.029010.1089/ten.tea.2016.0290 ↗
41. 10.1021/ja038085210.1021/ja0380852 ↗
42. 10.1016/j.materresbull.2012.11.04810.1016/j.materresbull.2012.11.048 ↗
43. 10.1039/B917103G10.1039/B917103G ↗
44. 10.1039/b821416f10.1039/b821416f ↗
45. 10.1021/jp806751k10.1021/jp806751k ↗
46. 10.1039/c2nr33158f10.1039/c2nr33158f ↗
47. Xie G. Q. · J. Mater. Chem. · 2012 · 22 · 25485
48. 10.1088/0022-3727/36/13/20110.1088/0022-3727/36/13/201 ↗
49. 10.1371/journal.pone.017254210.1371/journal.pone.0172542 ↗
50. Long J. T. · J. Nanobiotechnol. · 2014 · 12 · 3710.1186/s12951-014-0037-5 ↗
51. Gautam Singhvi M. S. · Int. J. Pharm. Stud. Res. · 2011 · 77
52. 10.1002/smll.20090168010.1002/smll.200901680 ↗
53. 10.1021/jp500709m10.1021/jp500709m ↗
54. 10.1016/j.carbpol.2012.07.07110.1016/j.carbpol.2012.07.071 ↗
55. 10.1016/j.nano.2016.12.01210.1016/j.nano.2016.12.012 ↗
56. 10.1074/jbc.M40094420010.1074/jbc.M400944200 ↗
57. 10.1146/annurev.biochem.68.1.38310.1146/annurev.biochem.68.1.383 ↗
58. 10.1039/C4NR03482A10.1039/C4NR03482A ↗
59. 10.1245/s10434-014-4301-610.1245/s10434-014-4301-6 ↗
60. 10.1245/s10434-014-3483-210.1245/s10434-014-3483-2 ↗
61. 10.1371/journal.pone.011362010.1371/journal.pone.0113620 ↗
62. 10.1016/j.actbio.2015.12.01510.1016/j.actbio.2015.12.015 ↗
63. Hina Kouser Shaikh R. V. K. · World J. Pharm. Res. · 2015 · 4 · 324